Piper Sandler Upgrades AMAG Pharmaceuticals (AMAG) to Neutral

October 1, 2020 12:22 PM EDT Send to a Friend
Piper Sandler analyst Christopher J. Raymond upgraded AMAG Pharmaceuticals (NASDAQ: AMAG) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to Premium below (Free Trial) LEARN MORE

Member Login